Polymer Capital Management’s DexCom DXCM Stock Holding History

Polymer Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,151	Closed	-$750K	–	818
2025 Q3	$750K	Buy	+11,151	New	+$882K	0.08%	293

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Polymer Capital Management's DXCM Position: Q4 2025 in Review

Polymer Capital Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 11,151 shares — an estimated $750K sold.

Polymer Capital Management first reported a position in DXCM in Q3 2025 and held it in 1 quarter. The position peaked at $750K in Q3 2025. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Polymer Capital Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Polymer Capital Management sold 11,151 DexCom shares in Q4 2025, an estimated $750K.
Polymer Capital Management first reported a position in DexCom in Q3 2025 and held it in 1 quarter.
Polymer Capital Management's DexCom position peaked at $750K in Q3 2025.
921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Polymer Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.